The emerging role of TH17 cells in organ transplantation

Transplantation

Volumn 97, Issue 5, 2014, Pages 483-489

  Sullivan, Jeremy A ^a   Adams, Andrew B ^b   Burlingham, William J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Collagen type V; IL 23; Monocytes; P2X7; TH17; Transplantation

Indexed keywords

COLLAGEN TYPE 5; INTERLEUKIN 17; INTERLEUKIN 1BETA; PURINERGIC P2X7 RECEPTOR;

ADAPTIVE IMMUNITY; ALLOIMMUNITY; ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CELLULAR IMMUNITY; CYTOKINE RELEASE; CYTOKINE RESPONSE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; NONHUMAN; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL;

ANIMALS; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSION; MODELS, ANIMAL; ORGAN TRANSPLANTATION; TH17 CELLS; TRANSPLANTATION TOLERANCE; TREATMENT OUTCOME;

EID: 84896288515     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0000000000000000     Document Type: Review

References (77)

1. Rouvier E, Luciani MF, Mattei MG, et al. CTLA-8, cloned from an activated T cell, bearing AU-rich messenger RNA instability sequences, and homologous to a herpesvirus saimiri gene. Journal of immunology 1993; 150: 5445
2. TeunissenMB, KoomenCW, deWaalMalefyt R, et al. Interleukin-17 and interferon-gamma synergize in the enhancement of proinflammatory cytokine production by human keratinocytes. J Invest Dermatol 1998; 111: 645
3. Kotake S, Udagawa N, Takahashi N, et al. IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis. J Clin Invest 1999; 103: 1345
4. Langrish CL, Chen Y, Blumenschein WM, et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005; 201: 233
5. Mosmann TR, Coffman RL. TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989; 7: 145
6. Cua DJ, Sherlock J, Chen Y, et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003; 421: 744
7. Bettelli E, Korn T, Oukka M, et al. Induction and effector functions of T(H)17 cells. Nature 2008; 453: 1051
8. Harrington LE, Hatton RD,Mangan PR, et al. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nature immunology 2005; 6: 1123
9. Park H, Li Z, Yang XO, et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005; 6: 1133
10. Sallusto F, Zielinski CE, Lanzavecchia A. Human Th17 subsets. Eur J Immunol 2012; 42: 2215
11. Kuchroo VK, Awasthi A. Emerging new roles of Th17 cells. Eur J Immunol 2012; 42: 2211
12. Awasthi A, Kuchroo VK. IL-17A directly inhibits TH1 cells and thereby suppresses development of intestinal inflammation. Nat Immunol 2009; 10: 568
13. Fantini MC, Becker C, Monteleone G, et al. Cutting edge: TGF-beta induces a regulatory phenotype in CD4+CD25-T cells through Foxp3 induction and down-regulation of Smad7. J Immunol 2004; 172: 5149
14. Ivanov II, McKenzie BS, Zhou L, et al. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 2006; 126: 1121
15. Mathur AN, Chang HC, Zisoulis DG, et al. Stat3 and Stat4 direct development of IL-17-secreting Th cells. J Immunol 2007; 178: 4901
16. Mathur AN, Chang HC, Zisoulis DG, et al. T-bet is a critical determinant in the instability of the IL-17-secreting T-helper phenotype. Blood 2006; 108: 1595
17. Lee Y, Awasthi A, Yosef N, et al. Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 2012; 13: 991
18. Voorhis MV, Fechner JH, Zhang X, et al. The aryl hydrocarbon receptor: A novel target for immunomodulation in organ transplantation. Transplantation 2013; 95: 983
19. Singh SP, Zhang HH, Foley JF, et al. Human T cells that are able to produce IL-17 express the chemokine receptor CCR6. J Immunol 2008; 180: 214
20. Wilson NJ, Boniface K, Chan JR, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 2007; 8: 950
21. Manel N, Unutmaz D, Littman DR. The differentiation of human T(H)-17 cells requires transforming growth factor-beta and induction of the nuclear receptor RORgammat. Nat Immunol 2008; 9: 641
22. Zielinski CE, Mele F, Aschenbrenner D, et al. Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 2012; 484: 514
23. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117: 3498
24. Maasho K, Masilamani M, Valas R, et al. The inhibitory leukocyteassociated Ig-like receptor-1 (LAIR-1) is expressed at high levels by human naive T cells and inhibits TCR mediated activation. Mol Immunol 2005; 42: 1521
25. Tang X, Tian L, Esteso G, et al. Leukocyte-Associated Ig-like receptor-1-deficient mice have an altered immune cell phenotype. J Immunol 2012; 188: 548
26. Yoshida S, Haque A, Mizobuchi T, et al. Anti-Type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 2006; 6: 724
27. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, et al. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol 2007; 8: 942
28. Bobadilla JL, Love RB, Jankowska-Gan E, et al. Th-17, monokines, collagen type V, and primary graft dysfunction in lung transplantation. Am J Respir Crit Care Med 2008; 177: 660
29. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 1996; 87: 2095
30. Murphy JE, Robert C, Kupper TS. Interleukin-1 and cutaneous inflammation: A crucial link between innate and acquired immunity. J Invest Dermatol 2000; 114: 602-8
31. Cho JS, Guo Y, Ramos RI, et al. Neutrophil-derived IL-1beta is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog 2012; 8: E1003047
32. Ferrari D, Pizzirani C, Adinolfi E, et al. The P2-7 receptor: A key player in IL-1 processing and release. J Immunol 2006; 176: 3877
33. Solle M, Labasi J, Perregaux DG, et al. Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 2001; 276: 125
34. Pelegrin P, Surprenant A. Pannexin-1 mediates large pore formation and interleukin-1beta release by the ATP-gated P2-7 receptor. EMBO J 2006; 25: 5071
35. Davis BK, Wen H, Ting JP. The inflammasome NLRs in immunity, inflammation, and associated diseases. Annu Rev Immunol 2011; 29: 707
36. Burns K, Martinon F, Tschopp J. New insights into the mechanism of IL-1beta maturation. Curr Opin Immunol 2003; 15: 26
37. Martinon F, Burns K, Tschopp J. The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 2002; 10: 417
38. Franco C, Ahmad PJ, Hou G, et al. Increased cell and matrix accumulation during atherogenesis in mice with vessel wall-specific deletion of discoidin domain receptor 1. Circ Res 2010; 106: 1775
39. Yang C, Park AC, Davis NA, et al. Comprehensive mass spectrometric mapping of the hydroxylated amino acid residues of the alpha1(V) collagen chain. J Biol Chem 2012; 287: 40598
40. Dart ML, Jankowska-Gan E, Huang G, et al. Interleukin-17-dependent autoimmunity to collagen type V in atherosclerosis. Circ Res 2010; 107: 1106
41. Lasiglie D, Traggiai E, Federici S, et al. Role of IL-1 beta in the development of human T(H)17 cells: Lesson from NLPR3 mutated patients. PLoS One 2011; 6: E20014
42. Neofytos D, Fishman JA, Horn D, et al. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Transpl Infect Dis 2010; 12: 220
43. Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients: Results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101
44. Patterson JE. Epidemiology of fungal infections in solid organ transplant patients. Transpl Infect Dis 1999; 1: 229
45. Cheng SC, van De Veerdonk FL, Lenardon M, et al. The dectin-1/ inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol 2011; 90: 357
46. Goers TA, Ramachandran S, Aloush A, et al. De novo production of K-Alpha1 tubulin-specific antibodies: Role in chronic lung allograft rejection. J Immunol 2008; 180: 4487
47. Loza MJ, Anderson AS, O'Rourke KS, et al. T-cell specific defect in expression of the NTPDase CD39 as a biomarker for lupus. Cell Immunol 2011; 271: 110
48. Peelen E, Damoiseaux J, Smolders J, et al. Th17 expansion in MS patients is counterbalanced by an expanded CD39+ regulatory T cell population during remission but not during relapse. J Neuroimmunol 2011; 240-241: 97
49. Fletcher JM, Lonergan R, Costelloe L, et al. CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis. J Immunol 2009; 183: 7602
50. Borsellino G, Kleinewietfeld M, Di Mitri D, et al. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: Hydrolysis of extracellular ATP and immune suppression. Blood 2007; 110: 1225
51. Deaglio S, Dwyer KM, GaoW, et al. Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257
52. Kochetkova I, Golden S,Holderness K, et al. IL-35 stimulation of CD39+ regulatory T cells confers protection against collagen II-induced arthritis via the production of IL-10. J Immunol 2010; 184: 7144
53. Duhen T, Duhen R, Lanzavecchia A, et al. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood 2012; 119: 4430
54. Corbett JM, Wheeler CH, Dunn MJ. Coelectrophoresis of cardiac tissue from human, dog, rat and mouse: Towards the establishment of an integrated two-dimensional protein database. Electrophoresis 1995; 16: 1524
55. Fukami N, Ramachandran S, Saini D, et al. Antibodies to MHC class I induce autoimmunity: Role in the pathogenesis of chronic rejection. J Immunol 2009; 182: 309
56. Daniel C, Horvath S, Allen PM. A basis for alloreactivity: MHC helical residues broaden peptide recognition by the TCR. Immunity 1998; 8: 543
57. Scott-Browne JP, Crawford F, Young MH, et al. Evolutionarily conserved features contribute to alphabeta T cell receptor specificity. Immunity 2011; 35: 526
58. Adams AB, Williams MA, Jones TR, et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003; 111: 1887
59. D'Orsogna LJ, van Der Meer-Prins EM, Zoet YM, et al. Detection of allo-HLA cross-reactivity by virus-specific memory T-cell clones using single HLA-Transfected K562 cells. Methods Mol Biol 2012; 882: 339
60. Lechler RI, Lombardi G, Batchelor JR, et al. The molecular basis of alloreactivity. Immunology today 1990; 11: 83
61. Benichou G, Takizawa PA, Olson CA, et al. Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection. J Exp Med 1992; 175: 305
62. Rolls HK, Kishimoto K, Illigens BM, et al. Detection of cardiac myosin-specific autoimmunity in a model of chronic heart allograft rejection. Transplant Proc 2001; 33: 3821
63. Brennan TV, Jaigirdar A, Hoang V, et al. Preferential priming of alloreactive T cells with indirect reactivity. Am J Transplant 2009; 9: 709
64. Carrodeguas L, Orosz CG, Waldman WJ, et al. Trans vivo analysis of human delayed-Type hypersensitivity reactivity. Hum Immunol 1999; 60: 640
65. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000; 106: 145
66. Lingaraju R, Pochettino A, Blumenthal NP, et al. Lung transplant outcomes in white and African American recipients: Special focus on acute and chronic rejection. J Heart Lung Transplant 2009; 28: 8
67. Vanaudenaerde BM, De Vleeschauwer SI, Vos R, et al. The role of the IL23/IL17 axis in bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant 2008; 8: 1911
68. Fan L, Benson HL, Vittal R, et al. Neutralizing IL-17 prevents obliterative bronchiolitis in murine orthotopic lung transplantation. Am J Transplant 2011; 11: 911
69. Suciu-Foca N, Cohen DJ, Benvenisty AI, et al. Influence of HLA matching on kidney allograft survival. Transplant Proc 1996; 28: 121
70. Glysing-Jensen T, Raisanen-Sokolowski A, Sayegh MH, et al. Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts. Transplantation 1997; 64: 1641
71. Haynes LD, Jankowska-Gan E, Sheka A, et al. Donor-specific indirect pathway analysis reveals a B-cell-independent signature which reflects outcomes in kidney transplant recipients. Am J Transplant 2012; 12: 640
72. Vergani A., Tezza S, D'Addio F, et al. Long-Term heart transplant survival by targeting the ionotropic purinergic receptor P2-7. Circulation 2013; 127: 463
73. Vergani A, Fotino C, D'Addio F, et al. Effect of the Purinergic Inhibitor Oxidized-ATP in a Model of Islet Allograft Rejection. Diabetes 2013; 62: 1665
74. Vanaudenaerde BM, Wuyts WA, Geudens N, et al. Macrolides inhibit IL17-induced IL8 and 8-isoprostane release from human airway smooth muscle cells. Am J Transplant 2007; 7: 76
75. Vanaudenaerde BM, Meyts I, Vos R, et al. A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy. Eur Respir J 2008; 32: 832
76. Wu C, Yosef N, Thalhamer T, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature 2013; 496: 513
77. Hutchinson JA, Riquelme P, Sawitzki B, et al. Cutting Edge: Immunological consequences and trafficking of human regulatory macrophages administered to renal transplant recipients. J Immunol 2011; 187: 2072